4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-034878
Director sold 5,000 shares at $39.79 ($198,950)
- Director acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DOBMEIER ERIC Director | 2020-06-03 | Option exercise | +5,000 | $6.32 | $31,600 | 5,000 | D: show line 1 in the form |
| DOBMEIER ERIC Director | 2020-06-03 | Sale | −5,000 | $39.79 | $198,950 | 0 | D: show line 2 in the form |
| Open-market sales · 5,000 sh · avg $39.79 · $198,950 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| DOBMEIER ERIC Director | 2020-06-03 | Option exercise · Stock Option (Right to Buy) | −5,000 | 65,000 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…